Journal of Venomous Animals and Toxins including Tropical Diseases

Journal of Venomous Animals and Toxins including Tropical Diseases is published by BioMed Central and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Venomous Animal Envenomation and Studies, Ion channel regulation and function and Marine Invertebrate Physiology and Ecology, together about 47.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Brief History The Journal of Venomous Animals and Toxins including Tropical Diseases (JVATiTD) – ISSN 1678-9199 – was founded in 1995 by the Center for the Study of Venoms and Venomous Animals (Cevap/Unesp), initially under the title Journal of Venomous Animals and Toxins. Since its inception, the journal has sought innovation, being one of the first Brazilian scientific publications in digital format, initially distributed on floppy disks and later on CD-ROM, prior to the widespread dissemination of the internet in the country. In 1998, it was selected to join the Scientific Electronic Library Online (SciELO) program, consolidating its place in the electronic scholarly communication scenario.From 2003 onward, with the expansion of its scope to include tropical diseases, the journal adopted its current name and began operating entirely online, with electronic submission and access. Over the years, the journal has established itself as an important international outlet in toxinology and tropical diseases, increasing its visibility through key indexings, including PubMed and PubMed Central, alongside the adoption of a continuous publication model starting in 2013. This process was accompanied by consistent growth in its bibliometric indicators and the strengthening of its internationalization.In recent years, especially after 2020, JVATiTD has maintained its evolutionary trajectory through continuous publication and the reinforcement of its policy for the broad and free dissemination of scientific knowledge. In partnership with SciELO, the journal reaffirms its commitment to open science, editorial transparency, and global visibility, adapting to the transformations of contemporary scholarly communication. In 2025, the journal celebrated 30 years of history, consolidating its position as an international reference in toxinology and tropical diseases, while remaining aligned with best editorial practices and open access principles. Open Access JVATiTD follows the open access model, formally adhering to the DOAJ (Directory of Open Access Journals) definition of open access, providing immediate, worldwide, unrestricted online access to all published scientific content. Under this policy, authors retain copyright and grant third parties use rights under the Creative Commons Attribution (CC BY 4.0). This permits any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to softwar

From the journal's Aims & Scope

Research area (LetPub): Toxicology

Editorial board by country: none in mainland China; most named France 3, United Kingdom 1, Brazil 1, Türkiye 1, Belgium 1 (13 members with a country) Editorial board ↗Publisher website · 2026-09-29

CAS Journal Ranking

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

Web of ScienceMEDLINEPMCEmbaseCASCAB AbstractsSciELOPublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

2.5LetPub · 2026-09-13

CiteScore 2026-06

3.6LetPub · 2026-09-13

CiteScore (publisher)

3.6Publisher website · 2026-09-29

SJR 2026-06

0.46LetPub · 2026-09-13

SNIP 2026-06

0.71LetPub · 2026-09-13

h-index

22LetPub · 2026-09-13

h-index

59OpenAlex · 2026-10-01

i10-index

590OpenAlex · 2026-10-01

2-year mean citedness

2.07OpenAlex · 2026-10-01

Self-citation rate

4%LetPub · 2026-09-13

Share of gold OA articles

98.48%LetPub · 2026-09-13

Volume

Articles per year

22LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

6–12 weeksLetPub · 2026-09-13

Average acceptance (community reports)

EasyLetPub · 2026-09-13

Submission to publication (journal-reported)

about 15 weeksDOAJ · 2026-10-25

Peer review

Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

• APC information ↗DOAJ
• Fee waivers ↗DOAJ
• Open access statement ↗DOAJ
• License & copyright ↗DOAJ

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

BioMed Central

Country or region

BRAZIL

Language

English

Frequency

Quarterly

Founded

2013

ISSN

1678-9199

Official links

• Journal homepage ↗DOAJ
• Submission system ↗Publisher website
• Author guidelines ↗DOAJ
• Aims & Scope ↗DOAJ
• APC information ↗DOAJ
• Fee waivers ↗DOAJ
• Open access statement ↗DOAJ
• License & copyright ↗DOAJ
• Peer review process ↗DOAJ
• Editorial board ↗DOAJ
• Plagiarism policy ↗DOAJ